Publicaciones en colaboración con investigadores/as de University of Sassari (11)

2015

  1. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

2012

  1. 5-Fluorouracil derivatives: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 22, Núm. 2, pp. 107-123

  2. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

    Journal of Translational Medicine, Vol. 10, Núm. 1

2011

  1. E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells

    Bioengineered Bugs, Vol. 2, Núm. 3, pp. 163-167

2009

  1. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo

    Journal of Molecular Medicine, Vol. 87, Núm. 9, pp. 899-911

2006

  1. Differentiation: An encouraging approach to anticancer therapy

    Italian Journal of Anatomy and Embryology, Vol. 111, Núm. 1, pp. 45-64

2003

  1. Contractile regulatory proteins tropomyosin and troponin-T as indicators of the modulatory role of retinoic acid

    Cells Tissues Organs, Vol. 175, Núm. 1, pp. 25-33

  2. Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells

    Neoplasma, Vol. 50, Núm. 2, pp. 91-96

2000

  1. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)

    Japanese Journal of Cancer Research, Vol. 91, Núm. 9, pp. 934-940

1999

  1. GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

    British Journal of Cancer, Vol. 79, Núm. 5-6, pp. 807-813

1998

  1. Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR

    Japanese Journal of Cancer Research, Vol. 89, Núm. 5, pp. 525-532